Daiwa Securities Group Inc. Sells 200 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Daiwa Securities Group Inc. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 9.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,000 shares of the company’s stock after selling 200 shares during the period. Daiwa Securities Group Inc.’s holdings in HealthEquity were worth $172,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. Dimensional Fund Advisors LP boosted its holdings in HealthEquity by 8.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,409,740 shares of the company’s stock worth $93,466,000 after acquiring an additional 108,108 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in HealthEquity by 2.9% in the fourth quarter. Principal Financial Group Inc. now owns 350,666 shares of the company’s stock worth $23,249,000 after acquiring an additional 9,926 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its holdings in HealthEquity by 7.6% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 8,898 shares of the company’s stock worth $590,000 after acquiring an additional 631 shares in the last quarter. Norges Bank bought a new position in HealthEquity in the fourth quarter worth approximately $43,482,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in HealthEquity in the fourth quarter worth approximately $871,000. Institutional investors own 99.55% of the company’s stock.

Insiders Place Their Bets

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the transaction, the director now directly owns 6,070 shares of the company’s stock, valued at $497,072.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The disclosure for this sale can be found here. Insiders sold 75,031 shares of company stock valued at $6,103,625 over the last ninety days. 2.20% of the stock is currently owned by insiders.

HealthEquity Stock Performance

NASDAQ:HQY opened at $78.80 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The business has a fifty day simple moving average of $76.14 and a two-hundred day simple moving average of $79.39. HealthEquity, Inc. has a 1 year low of $61.81 and a 1 year high of $88.26. The company has a market capitalization of $6.88 billion, a P/E ratio of 85.29, a P/E/G ratio of 1.19 and a beta of 0.52.

Wall Street Analyst Weigh In

HQY has been the topic of several recent research reports. Barrington Research reiterated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, August 30th. JMP Securities reissued a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Robert W. Baird increased their price objective on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. KeyCorp increased their price objective on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 5th. Finally, Wells Fargo & Company increased their price objective on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday, June 20th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $103.83.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.